A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care
Public ClinicalTrials.gov record NCT03733444. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Two Doses of GLPG1690 in Addition to Local Standard of Care for Minimum 52 Weeks in Subjects With Idiopathic Pulmonary Fibrosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study was to see how GLPG1690 works together with the current standard treatment on your lung function and IPF disease in general. The study also investigated how well GLPG1690 is tolerated (for example if you get any side effects while on study drug).
Study identification
- NCT ID
- NCT03733444
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 781 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 4, 2018
- Primary completion
- Mar 29, 2021
- Completion
- Mar 29, 2021
- Last update posted
- Jul 28, 2022
2018 – 2021
United States locations
- U.S. sites
- 36
- U.S. states
- 21
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Arizona Pulmonary Specialists | Phoenix | Arizona | 85012 | — |
| University of Arizona College of Medicine | Tucson | Arizona | 85724 | — |
| Keck School of Medicine of USC | Los Angeles | California | 90033 | — |
| Cedars Sinai Medical Center | Los Angeles | California | 90048 | — |
| UC Davis Medical Center | Sacramento | California | 95816 | — |
| University of California, San Francisco Medical Center | San Francisco | California | 94143 | — |
| St. Francis Medical Institute | Clearwater | Florida | 33765 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Renstar Medical Research | Ocala | Florida | 34470 | — |
| Central Florida Pulmonary Group PA | Orlando | Florida | 32803 | — |
| Piedmont Healthcare | Atlanta | Georgia | 30309 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Loyola University Medical Center | Maywood | Illinois | 60153 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Brigham and Womens Hospital | Boston | Massachusetts | 02115 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| University of Michigan Health System (UMHS) | Ann Arbor | Michigan | 48109 | — |
| Spectrum Health Medical Group | Grand Rapids | Michigan | 49546 | — |
| University of Minnesota Medical Center | Minneapolis | Minnesota | 55455 | — |
| Cardio Pulmonary Associates | Chesterfield | Missouri | 63017 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03765 | — |
| Atlantic Respiratory Institute | Summit | New Jersey | 07901 | — |
| Lovelace Scientific Resources Inc | Albuquerque | New Mexico | 87108 | — |
| Albany Medical Center | Albany | New York | 12208 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Ohio State University | Columbus | Ohio | 43203 | — |
| Mercy Health - St. Vincent Medical Center | Toledo | Ohio | 43608 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Temple Lung Center | Philadelphia | Pennsylvania | 19140 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| Medical University of South Carolina - PPDS | Charleston | South Carolina | 29425 | — |
| University of Vermont | Burlington | Vermont | 05401 | — |
| Inova Fairfax Hospital | Falls Church | Virginia | 22042 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 96 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03733444, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 28, 2022 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03733444 live on ClinicalTrials.gov.